World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)

This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests.  Together, these three in vitro diagnostic areas represent nearly one-half of the IVD market and the best growth opportunities. The Bundle features the exact published content in each of the three major Kalorama studies, sold as intact PDFs with separate table of contents, including the following:

• The World Market for Molecular Diagnostics, 6th Edition
  • In the World Market for Molecular Diagnostics, 6th Edition, Kalorama IVD market analyst Shara Rosen, R.T., MBA provides complete analysis of the IVD molecular testing kit and reagent industry by segment. In this report, exclusive  market sizing and forecasts are provided for the following diagnostic segments:
    • Cancer Markers & PGx
    • Histology (In situ hybridization, HPV)
    • Microbiology/Virology (HAI; HIV; Hepatitis; GC/Chlamydia; Respiratory;Organism ID; Mycobacteria, TB; Others)
    • Blood Screening
    • Coagulation & PGx
    • Prenatal Testing
    • Inherited Diseases Testing
    • Tissue Typing
    • Organ Transplant Testing (HLA Typing)
    • Circulating Tumor Cells (CTCs)
    • Clinical Sequencing
    • Flow Cytometry
    The amount of activity over the last few years is short of phenomenal with a continuous stream of new platforms, tests  and quality control materials for test standardization coming to market. There is intense competition but also opportunities for entrants in some areas.
• The World Market for Cancer Diagnostics, 6th Edition
• Kalorama has, in five previous editions of The World Market for Cancer Diagnostics, defined the oncology testing market. This 850-page report contains detailed market data on the following IVD segments for their use in cancer diagnostics:
• Cancer IVD Market
• Cancer Test Services Market
• Sequencing in Cancer Testing
• Tissue Function Tests
• PSA, CEA and Other Immunoassays
• Flow Cytometry
• Pap and HPV Testing
• FOB and Other Rapid Tests
• Molecular Oncology Assays
• Tissue Microarrays
• Methylated DNA
• In situ hybridization (ISH)
• Immunohistochemistry (IHC)
• Circulating Tumor Cells
• Companion Testing and CDX Products
The report also details investments and financing agreements for cancer diagnostics companies, selected agreements between cancer diagnostic companies, selected agreements between cancer diagnostic companies and other diagnostic companies, pharmaceutical companies and non-profit organizations, and selected acquisitions of cancer diagnostic companies. The report provides detailed company profiles in several sections.
• The World Market for Infectious Disease Diagnostics
• This Kalorama Information report, The World Market for Infectious Disease Tests, contains detailed market estimates and forecasts for four major areas of infectious disease testing. Specific market details provided include:
• ID/AST Test Market by Type (Auto ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Micro)
• ID/AST Leader Market Shares
• Infectious Disease Immunoassays by Type (Lab-Based, POC, Home Testing)
• Laboratory Infectious Disease
• Immunoassays Sales by Disease(Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, STDs, ToRCH, Others)
• Infectious Disease Diagnostic Sales by Region – North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
• Blood Screening Test Market Size and Company Market Share
Trends in infectious diseases and in products are discussed. The information contained in this report has been assembled from primary and secondary data. Primary research was conducted via telephone conversations with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine